CRELD2 Antikörper (AA 31-130)
-
- Target Alle CRELD2 Antikörper anzeigen
- CRELD2 (Cysteine-Rich with EGF-Like Domains 2 (CRELD2))
-
Bindungsspezifität
- AA 31-130
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CRELD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Maus
- Homologie
- Human,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CRELD2
- Isotyp
- IgG
- Top Product
- Discover our top product CRELD2 Primärantikörper
-
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) antibody
CRELD2 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 325-353), (C-Term) antibodyCRELD2 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB23267 unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 162-258) antibodyCRELD2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 1-321) antibodyCRELD2 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 23-51), (N-Term) antibodyCRELD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39214 unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 162-258) antibodyCRELD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2B6 unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 135-184) antibodyCRELD2 Reaktivität: Human, Hund, Schwein, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cysteine-Rich with EGF-Like Domains 2 (CRELD2) (AA 324-353), (C-Term) antibodyCRELD2 Reaktivität: Human WB, FACS, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- CRELD2 (Cysteine-Rich with EGF-Like Domains 2 (CRELD2))
- Andere Bezeichnung
- Creld2 (CRELD2 Produkte)
- Synonyme
- zgc:66383 antikoerper, CRELD2 antikoerper, 5730592L21Rik antikoerper, C85758 antikoerper, RGD1310614 antikoerper, cysteine-rich with EGF-like domains 2 antikoerper, cysteine rich with EGF like domains 2 antikoerper, creld2 antikoerper, CRELD2 antikoerper, Creld2 antikoerper
- Hintergrund
-
Synonyms: CREL2_HUMAN, CRELD 2, CRELD2, Cysteine rich with EGF like domain protein 2, Cysteine rich with EGF like domains 2, Cysteine-rich with EGF-like domain protein 2, DKFZp667O055, MGC11256.
Background: May regulate transport of alpha4-beta2 neuronal acetylcholine receptor.
- Gen-ID
- 79174
-
